A Double-Blind, Placebo-Controlled Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Feb 2019
At a glance
- Drugs Brexpiprazole (Primary) ; Ketamine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 07 Feb 2019 Planned End Date changed from 31 Jan 2019 to 30 Apr 2019.
- 07 Feb 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Mar 2019.
- 07 Feb 2019 Status changed from recruiting to active, no longer recruiting.